Patents by Inventor Jayaraj Rajagopal

Jayaraj Rajagopal has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220221779
    Abstract: Provided herein are methods and compositions relating, in part, to the generation of human progenitor cells committed to the lung lineage and uses of such cells for treatment of lung diseases/disorders or injury to the lung. Whether an adult stem cell can be isolated from human adult lung remains controversial in the art and at present, methods for isolating and using adult lung stem cells from humans lack reproducibility. Thus, the methods and compositions described herein are advantageous over the present state of knowledge in the art and permit the generation of human lung progenitor cells for treatment, tissue engineering, and screening assays.
    Type: Application
    Filed: November 24, 2021
    Publication date: July 14, 2022
    Applicant: THE GENERAL HOSPITAL CORPORATION
    Inventors: Jayaraj Rajagopal, Hongmei Mou
  • Patent number: 11214769
    Abstract: Provided herein are methods and compositions relating, in part, to the generation of human progenitor cells committed to the lung lineage and uses of such cells for treatment of lung diseases/disorders or injury to the lung. Whether an adult stem cell can be isolated from human adult lung remains controversial in the art and at present, methods for isolating and using adult lung stem cells from humans lack reproducibility. Thus, the methods and compositions described herein are advantageous over the present state of knowledge in the art and permit the generation of human lung progenitor cells for treatment, tissue engineering, and screening assays.
    Type: Grant
    Filed: March 28, 2019
    Date of Patent: January 4, 2022
    Assignee: THE GENERAL HOSPITAL CORPORATION
    Inventors: Jayaraj Rajagopal, Hongmei Mou
  • Publication number: 20210115407
    Abstract: Provided herein are methods and compositions for identifying ionocytes from respiratory epithelial cells, and uses of such cells for treatment of inflammatory lung disease. Also provided herein are methods and compositions for modulating respiratory tract epithelial cell proliferation, differentiation, maintenance, and/or function.
    Type: Application
    Filed: April 12, 2018
    Publication date: April 22, 2021
    Inventors: Jayaraj Rajagopal, Aviv Regev, Moshe Biton, Adam Haber, Daniel Montoro, Orit Rozenblatt-Rosen
  • Publication number: 20210040442
    Abstract: An atlas of intestinal epithelial cells, intestinal epithelial stem cells and intestinal immune cells identifies new cell populations, markers, networks, and responses to stimuli. Intestinal epithelial cell sub-types are also found in the trachea. Accordingly, disclosed are methods of modulating epithelial cell differentiation, maintenance and/or function, related methods for the treatment of disease, including IBD and asthma. Also disclosed are methods and kits for identifying cell types, their differentiation, homeostasis and activation.
    Type: Application
    Filed: April 12, 2018
    Publication date: February 11, 2021
    Inventors: Jayaraj Rajagopal, Aviv Regev, Moshe Biton, Adam Haber, Daniel Montoro, Ramnik Xavier
  • Publication number: 20190276800
    Abstract: Provided herein are methods and compositions relating, in part, to the generation of human progenitor cells committed to the lung lineage and uses of such cells for treatment of lung diseases/disorders or injury to the lung. Whether an adult stem cell can be isolated from human adult lung remains controversial in the art and at present, methods for isolating and using adult lung stem cells from humans lack reproducibility. Thus, the methods and compositions described herein are advantageous over the present state of knowledge in the art and permit the generation of human lung progenitor cells for treatment, tissue engineering, and screening assays.
    Type: Application
    Filed: March 28, 2019
    Publication date: September 12, 2019
    Applicant: THE GENERAL HOSPITAL CORPORATION
    Inventors: Jayaraj Rajagopal, Hongmei Mou
  • Patent number: 10273450
    Abstract: Provided herein are methods and compositions relating, in part, to the generation of human progenitor cells committed to the lung lineage and uses of such cells for treatment of lung diseases/disorders or injury to the lung. Whether an adult stem cell can be isolated from human adult lung remains controversial in the art and at present, methods for isolating and using adult lung stem cells from humans lack reproducibility. Thus, the methods and compositions described herein are advantageous over the present state of knowledge in the art and permit the generation of human lung progenitor cells for treatment, tissue engineering, and screening assays.
    Type: Grant
    Filed: June 28, 2017
    Date of Patent: April 30, 2019
    Assignee: THE GENERAL HOSPITAL CORPORATION
    Inventors: Jayaraj Rajagopal, Hongmei Mou
  • Publication number: 20170369839
    Abstract: Provided herein are methods and compositions relating, in part, to the generation of human progenitor cells committed to the lung lineage and uses of such cells for treatment of lung diseases/disorders or injury to the lung. Whether an adult stem cell can be isolated from human adult lung remains controversial in the art and at present, methods for isolating and using adult lung stem cells from humans lack reproducibility. Thus, the methods and compositions described herein are advantageous over the present state of knowledge in the art and permit the generation of human lung progenitor cells for treatment, tissue engineering, and screening assays.
    Type: Application
    Filed: June 28, 2017
    Publication date: December 28, 2017
    Applicant: THE GENERAL HOSPITAL CORPORATION
    Inventors: Jayaraj Rajagopal, Hongmei Mou
  • Patent number: 9828583
    Abstract: Provided herein are methods and compositions relating, in part, to the generation of human progenitor cells committed to the lung lineage and uses of such cells for treatment of lung diseases/disorders or injury to the lung. Whether an adult stem cell can be isolated from human adult lung remains controversial in the art and at present, methods for isolating and using adult lung stem cells from humans lack reproducibility. Thus, the methods and compositions described herein are advantageous over the present state of knowledge in the art and permit the generation of human lung progenitor cells for treatment, tissue engineering, and screening assays.
    Type: Grant
    Filed: January 11, 2013
    Date of Patent: November 28, 2017
    Assignee: THE GENERAL HOSPITAL CORPORATION
    Inventors: Jayaraj Rajagopal, Hongmei Mou
  • Publication number: 20140329318
    Abstract: Provided herein are methods and compositions relating, in part, to the generation of human progenitor cells committed to the lung lineage and uses of such cells for treatment of lung diseases/disorders or injury to the lung. Whether an adult stem cell can be isolated from human adult lung remains controversial in the art and at present, methods for isolating and using adult lung stem cells from humans lack reproducibility. Thus, the methods and compositions described herein are advantageous over the present state of knowledge in the art and permit the generation of human lung progenitor cells for treatment, tissue engineering, and screening assays.
    Type: Application
    Filed: January 11, 2013
    Publication date: November 6, 2014
    Inventors: Jayaraj Rajagopal, Hongmei Mou